Article citationsMore>>

Jian, D., Jiang, D., Su, J., Chen, W., Hu, X., Kuang, Y., Xie, H., Li, J. and Chen, X. (2011) Diethylstilbestrol Enhances Melanogenesis via cAMP-PKA-Mediating Up-Regulation of Tyrosinase and MITF in Mouse B16 Melanoma Cells. Steroids, 76, 1297-1304.
http://dx.doi.org/10.1016/j.steroids.2011.06.008

has been cited by the following article:

• TITLE: Preliminary Colorimetric Assessment of Progressive Nonsegmental Vitiligo under Short-Term Intravenous Methylprednisolone Pulse Therapy

  AUTHORS: Yuiko Nagata, Atsushi Tanemura, Emi Ono, Aya Tanaka, Kenichi Kato, Mizuho Yamada, Ichiro Katayama

  KEYWORDS: Intravenous Methylprednisolone Pulse Therapy, Progressive Nonsegmental Vitiligo, Spectrophotometer

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.4 No.3, May 16, 2014

  ABSTRACT: Although the administration of systemic steroid for nonsegmental vitiligo in the progressive stage is a recommended treatment according to guidelines, the clinical efficacy of this regimen has not been fully established. In this study, we evaluated the clinical efficacy of half-dose steroid treatment and stratified the evidence regarding its usefulness in progressive vitiligo patients. Half-dose steroid pulse therapy (500 mg/day of methylprednisolone for three sequential days) was administered intravenously three times monthly in five vitiligo patients. The visual changes in vitiligo lesions were evaluated on photographs and quantified using a spectrophotometer. As results, all patients completed three cycles of treatment without severe adverse events. Three of the five patients achieved disease arrest with decrease in white contrast. Therefore, short-term and halfdose steroid therapy is well tolerated and effective for achieving disease arrest in progressive nonsegmental vitiligo. The whiteness assessed by a spectrophotometer is possibly associated with therapeutic response to steroid therapy.